申请人:Rhone-Poulenc Sante
公开号:US05130313A1
公开(公告)日:1992-07-14
This invention relates to compounds of formula: ##STR1## in which R.sub.1 denotes a 1,2,3,6-tetrahydro-1-pyridyl radical substituted in the 4-position by an optionally substituted phenyl, optionally substituted 3-indolyl or 3-(5-hydroxyindolyl) radical, a 1-piperazinyl radical substituted in the 4-position by an optionally substituted phenyl, 1,2-benzisothiazol-3-yl, 1,2-benzisoxazol-3-yl or 2-pyridyl radical, a piperidino radical substituted in the 4-position by an optionally substituted phenyl, bis(4-fluorophenyl)methylene, 4-fluorobenzoyl, optionally substituted 2-oxo-1-benzimidazolinyl, optionally substituted 3-indolyl or 3-(5-hydroxyindolyl) radical, by two phenyl radicals or a hydroxyl radical and an optionally substituted phenyl radical R.sub.2 denotes a radical SO.sub.2 R.sub.4 in which R.sub.4 denotes an alkyl or phenyl radical, R.sub.3 denotes a phenyl or naphthyl radical, or else R.sub.2 and R.sub.3 together with the nitrogen atom to which they are attached form a ring, n is equal to 2, 3 or 4, processes for their preparation and medications containing them. The invention relates to treating a disease ameliorated by serotonin.
本发明涉及以下式的化合物:##STR1##
其中,R1表示在4位上由可选取代苯基,可选取代3-吲哚基或3-(5-羟基吲哚基)基团取代的1,2,3,6-四氢-1-吡啶基基团,由可选取代苯基取代的1-哌嗪基团,1,2-苯并异噻唑-3-基团,1,2-苯并噁唑-3-基团或2-吡啶基基团,由可选取代苯基取代的4-位取代的哌啶基基团,双(4-氟苯基)亚甲基基团,4-氟苯甲酰基,可选取代的2-氧代-1-苯并咪唑啉基团,可选取代的3-吲哚基或3-(5-羟基吲哚基)基团,由两个苯基基团或一个羟基基团和一个可选取代苯基基团取代的基团。R2表示SO2R4基团,其中R4表示烷基或苯基基团,R3表示苯基或萘基团,或者R2和R3与它们所连接的氮原子一起形成环,n等于2、3或4。本发明还涉及制备这些化合物的方法和含有它们的药物。本发明涉及治疗一种通过血清素改善的疾病。